TCM
TMO icon

Thames Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Thames Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.49M Hold
13,202
– – 1.16% 31
2025
Q4 		$7.65M Hold
13,202
– – 1.11% 34
2025
Q3 		$6.4M Sell
13,202
-725
-5% -$337K 0.91% 42
2025
Q2 		$5.65M Hold
13,927
– – 1.28% 30
2025
Q1 		$6.93M Hold
13,927
– – 2.66% 18
2024
Q4 		$7.25M Hold
13,927
– – 1.96% 22
2024
Q3 		$8.61M Hold
13,927
– – 2.68% 18
2024
Q2 		$7.7M Hold
13,927
– – 3.02% 20
2024
Q1 		$8.09M Buy
13,927
+725
+5% +$407K 3.37% 16
2023
Q4 		$7.01M Hold
13,202
– – 3.61% 13
2023
Q3 		$6.68M Hold
13,202
– – 3.82% 10
2023
Q2 		$6.89M Hold
13,202
– – 3.67% 12
2023
Q1 		$7.61M Sell
13,202
-15,989
-55% -$9.01M 5.35% 8
2022
Q4 		$16.1M Sell
29,191
-1,478
-5% -$783K 7.63% 5
2022
Q3 		$15.6M Buy
30,669
+1,819
+6% +$1.02M 7.72% 4
2022
Q2 		$15.7M Hold
28,850
– – 6.29% 4
2022
Q1 		$17M Hold
28,850
– – 3.59% 7
2021
Q4 		$19.3M Sell
28,850
-114
-0.4% -$71.2K 3.69% 5
2021
Q3 		$16.5M Hold
28,964
– – 3.61% 5
2021
Q2 		$14.6M Hold
28,964
– – 3.43% 6
2021
Q1 		$13.2M Hold
28,964
– – 3.05% 5
2020
Q4 		$13.5M Hold
28,964
– – 3.79% 5
2020
Q3 		$12.8M Hold
28,964
– – 4.51% 5
2020
Q2 		$10.5M Hold
28,964
– – 4.12% 5
2020
Q1 		$8.21M Buy
28,964
+114
+0.4% +$35.9K 6.44% 5
2019
Q4 		$9.37M Sell
28,850
-10,080
-26% -$3.06M 3.11% 11
2019
Q3 		$11.3M Sell
38,930
-13,930
-26% -$3.99M 3.38% 15
2019
Q2 		$15.5M Buy
52,860
+7,440
+16% +$2.05M 4.39% 10
2019
Q1 		$12.4M Buy
+45,420
New +$11.3M 3.5% 13

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thames Capital Management's TMO Position: Q1 2026 in Review

Thames Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 13,202 shares worth $6.49M. The position accounts for 1.16% of the portfolio, ranked #31.

Thames Capital Management first reported a position in TMO in Q1 2019 and has held it in 29 quarters since. The position peaked at $19.3M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Thames Capital Management held 13,202 shares of Thermo Fisher Scientific worth $6.49M as of Q1 2026.
  • Thames Capital Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 1.16% of Thames Capital Management's portfolio in Q1 2026, its #31 holding.
  • Thames Capital Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 29 quarters since.
  • Thames Capital Management's Thermo Fisher Scientific position peaked at $19.3M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Thames Capital Management's 13F filing for Q1 2026, filed 12 May 2026.